Mercator Medical (FRA:MM2) ROE % Adjusted to Book Value: 12.84% (As of Mar. 2026)


FRA:MM2 Mercator Medical SA FRA:MM2
59 GF Score
Price €11.20
GF Value €11.71
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Mercator Medical ROE % Adjusted to Book Value?

Mercator Medical FRA:MM2 +0.18% 59 ROE % Adjusted to Book Value is 12.84% as of Mar. 2026. GuruFocus rates FRA:MM2 with a GF Score™ of 59/100 and a GF Value™ of €11.71 (Fairly Valued). The stock has 2 warning signs investors should review.

Mercator Medical's ROE % for the quarter that ended in Mar. 2026 was 5.78%. Mercator Medical's PB Ratio for the quarter that ended in Mar. 2026 was 0.45. Mercator Medical's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 12.84%.

Mercator Medical ROE % Adjusted to Book Value Related Terms

Mercator Medical ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Mercator Medical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercator Medical ROE % Adjusted to Book Value Chart

Mercator Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.81 -40.98 -4.88 10.44 8.24

Mercator Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.23 -8.74 4.82 3.95 12.84

FRA:MM2 vs ISRG, BDX, MDLN: ROE % Adjusted to Book Value Comparison

For the Medical Instruments & Supplies subindustry, Mercator Medical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mercator Medical ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mercator Medical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Mercator Medical's ROE % Adjusted to Book Value falls into.


FRA:MM2
59GF Score
Mercator Medical SA FRA:MM2
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mercator Medical ROE % Adjusted to Book Value Calculation

Mercator Medical's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=3.13% / 0.38
=8.24%

Mercator Medical's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=5.78% / 0.45
=12.84%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 12.84% mean?
Mercator Medical (FRA:MM2) has a ROE % Adjusted to Book Value of 12.84% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Mercator Medical and its competitors.
Is Mercator Medical's ROE % Adjusted to Book Value too high?
Mercator Medical's current ROE % Adjusted to Book Value is 12.84%. Overall, Mercator Medical has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's ROE % Adjusted to Book Value compare to ISRG and BDX?
Mercator Medical's ROE % Adjusted to Book Value of 12.84% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Mercator Medical and its competitors. Mercator Medical's current ROE % Adjusted to Book Value is 12.84%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Based on GuruFocus' analysis, Mercator Medical (FRA:MM2) is currently considered Fairly Valued. The stock's GF Value™ is €11.71, compared to a current price of €11.20 — trading 4.4% below its estimated fair value. The current ROE % Adjusted to Book Value is 12.84%. Mercator Medical's overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Mercator Medical (FRA:MM2), the current ROE % Adjusted to Book Value is 12.84% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mercator Medical (FRA:MM2) Overvalued in 2026?

Based on GuruFocus' analysis, Mercator Medical stock appears to be undervalued. The current stock price of €11.20 is trading 4.4% below its estimated GF Value™ of €11.71. GuruFocus considers Mercator Medical to be Fairly Valued.

Key valuation signals for FRA:MM2:

  • ROE % Adjusted to Book Value: 12.84%
  • GF Value™: €11.71 vs. price of €11.20 (4.4% below fair value)
  • GF Score™: 59/100 with 2 warning signs

No single metric tells the full story. See the FRA:MM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mercator Medical Business Description

Other Exchanges MRC:Poland
Address Ulica H. Modrzejewska 30, Krakow, POL, 31-327
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
59GF Score

Get the complete analysis for FRA:MM2

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.20
Price
€11.71
GF Value